Amarantus Bioscience Holdings, Inc. announced that it has entered into a Letter of Intent (‘LOI’) with The Alchemist’s Kitchen to establish a joint venture for commercialization of hemp based herbal smokable products ‘Herbal Smokes’ in addition to conducting research for cannabinoid derived addiction treatment, including smoking cessation (tobacco and vaping-based/e-cigarette), and other indications such as insomnia (the ‘Evolver Herbal Smokes’ or the ‘JV’). Under the terms of the agreement, The Alchemist’s Kitchen’s ‘Plant Alchemy’ brand, an ultra-premium brand of health & wellness products that include federally legal hemp derived cannabidiol (CBD) products, will be the brand used for the products produced from the joint venture. The Alchemist’s Kitchen is currently selling Plant Alchemy hemp-based smokable products out of their storefront in the Lower East Side in Manhattan, New York, and will contribute that currently selling Plant Alchemy smokable product line to the JV. Amarantus will contribute capital to the JV, will deploy its clinical development expertise and work closely with The Alchemist’s Kitchen to conduct clinical research on the use of the Herbal Smokes. The objective of the JV is to engage highly motivated consumers to participate in the necessary clinical development that will accelerate the path to claim-based hemp-derived products with the Food & Drug Administration. Ultimately, the objective is to create products that have been rigorously tested so that the JV can make medical claims regarding the benefits of Herbal Smokes products vs. other forms of smokable or inhalable products.